The European Forum on Antiphospholipid Antibodies was conceived as a multidisciplinary
network of different specialists working in the fields of internal medicine, haematology …

The European Forum on Antiphospholipid Antibodies provides a multidisciplinary network of
diverse experts with a common interest in antiphospholipid antibodies (aPL) and …

The European Forum on Antiphospholipid Antibodies is a multidisciplinary network of
different specialists that share a common interest in antiphospholipid antibodies (aPL) and …

The “V Meeting of the European Forum on Antiphospholipid Antibodies” was organized in
Barcelona, Catalonia, Spain, on December 2–3, 2005. This biannual meeting becomes a …

The 9th meeting of the European Forum on Antiphospholipid Antibodies (Euro aPL Forum)
was held in Krakow, Poland, on 16–18 May 2013. This was an excellent occasion for the …

The European Forum on Antiphospholipid Antibodies (aPL), initiated at the 7th international
meeting on aPL in New Orleans (Oct 1996) was proposed as an open space for discussion …

According to the Sydney criteria, antiphospholipid syndrome (APS) diagnosis is closely
related to the demonstration of antiphospholipid antibodies (aPL) in patients sera. For this …

The 10th International Congress on Antiphospholipid Antibodies (Sicily, Italy, September 29–
October 3, 2002)(Fig. 1) provided enlightening aspects on the recent developments in …

The main objective of these meetings is to promote international collaboration in various
clinical and research projects. This paper is the summary of the 2007 Ljubljana meeting, and …

The laboratory criteria (lupus anticoagulants (LA), and/or anti-cardiolipin (aCL) antibodies
and/or anti-β2-glycoprotein I antibodies (aβ2GPI)) that define patients with antiphospholipid …